A Phase 2, multicenter, single-arm, open label study to evaluate the efficacy and safety of AK104 in subjects with recurrent or metastatic cervical cancer

Project: Research

Project Details

StatusActive
Effective start/end date18/06/2017/06/25

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • cervical cancer
  • phase 2 study